GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (FRA:CRO) » Definitions » Equity Investments

hVIVO (FRA:CRO) Equity Investments


View and export this data going back to 2019. Start your Free Trial

What is hVIVO Equity Investments?

Equity Investments only applies to insurance companies.


hVIVO (FRA:CRO) Business Description

Traded in Other Exchanges
Address
42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.